Xynos Konstantinos - Insider Non-Derivative Transactions at Replimune Group, Inc. (REPL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Xynos Konstantinos's relationship to Replimune Group, Inc. (REPL) is Officer (Chief Medical Officer), and currently has 199,685 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other REPL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Xynos Konstantinos - Insider Non-Derivative Transactions of REPL Common Stock

Xynos Konstantinos - Insider Non-Derivative Transactions at REPL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	Acquisition -- (Common Stock)	60000	0	199685
Nov 18, 2025	Sell -- (Common Stock)	7248	9.1	139685
May 21, 2025	Sell -- (Common Stock)	7952	8.06	146933
Apr 2, 2025	Acquisition -- (Common Stock)	45000	0	154885
Nov 19, 2024	Sell -- (Common Stock)	7246	10.78	109885
Jun 8, 2024	Sell -- (Common Stock)	15881	7.5	117131
May 17, 2024	Sell -- (Common Stock)	6367	6.47	133012
Apr 2, 2024	Acquisition -- (Common Stock)	26665	0	139379
Nov 17, 2023	Sell -- (Common Stock)	7313	10.92	112714
May 17, 2023	Sell -- (Common Stock)	771	18.05	120027
Apr 2, 2023	Acquisition -- (Common Stock)	50000	0	120798